Oculis Holding AG Warrants
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-opht… Read more
Oculis Holding AG Warrants (OCSAW) - Total Assets
Latest total assets as of June 2024: $138.73 Million USD
Based on the latest financial reports, Oculis Holding AG Warrants (OCSAW) holds total assets worth $138.73 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oculis Holding AG Warrants - Total Assets Trend (2020–2023)
This chart illustrates how Oculis Holding AG Warrants’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oculis Holding AG Warrants - Asset Composition Analysis
Current Asset Composition (December 2023)
Oculis Holding AG Warrants's total assets of $138.73 Million consist of 88.3% current assets and 11.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 33.5% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $12.21 Million | 10.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2023)
This chart illustrates how Oculis Holding AG Warrants's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oculis Holding AG Warrants's current assets represent 88.3% of total assets in 2023, an increase from 37.6% in 2020.
- Cash Position: Cash and equivalents constituted 33.5% of total assets in 2023, up from 30.2% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 10.7% of total assets.
Oculis Holding AG Warrants Competitors by Total Assets
Key competitors of Oculis Holding AG Warrants based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Oculis Holding AG Warrants - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Oculis Holding AG Warrants generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oculis Holding AG Warrants is currently not profitable relative to its asset base.
Oculis Holding AG Warrants - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.27 | 7.22 | 11.81 |
| Quick Ratio | 5.27 | 7.22 | 11.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $101.00 Million | $ 104.56 Million | $ 43.92 Million |
Oculis Holding AG Warrants - Advanced Valuation Insights
This section examines the relationship between Oculis Holding AG Warrants's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 208.6% |
| Total Assets | $114.35 Million |
| Market Capitalization | $161.26K USD |
Valuation Analysis
Below Book Valuation: The market values Oculis Holding AG Warrants's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Oculis Holding AG Warrants's assets grew by 208.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Oculis Holding AG Warrants (2020–2023)
The table below shows the annual total assets of Oculis Holding AG Warrants from 2020 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $114.35 Million | +208.56% |
| 2022-12-31 | $37.06 Million | -36.15% |
| 2021-12-31 | $58.04 Million | +254.29% |
| 2020-12-31 | $16.38 Million | -- |